{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:13:55Z","timestamp":1788880435870,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103028","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:55:49Z","timestamp":1784678149000},"page":"103028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intranasal Tat-modified PEG-PCL nanomicelles delivering anti-RelA siRNA attenuate ischemia-reperfusion injury"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4383-9702","authenticated-orcid":false,"given":"Mitsuyoshi","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7046-9620","authenticated-orcid":false,"given":"Takayuki","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2730-1297","authenticated-orcid":false,"given":"Taiki","family":"Nagatomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7513-5132","authenticated-orcid":false,"given":"Yasuhiro","family":"Kosuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyofumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-1564","authenticated-orcid":false,"given":"Takanori","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103028_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study (2021)","volume":"23","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2026.103028_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7861\/clinmedicine.17-2-154","article-title":"The latest national clinical guideline for stroke","volume":"17","author":"Rudd","year":"2017","journal-title":"Clin. Med."},{"key":"10.1016\/j.omtn.2026.103028_bib3","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/01.STR.0000217418.29609.22","article-title":"Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review","volume":"37","author":"Bandera","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.omtn.2026.103028_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresrev.2006.11.003","article-title":"Molecular targets in cerebral ischemia for developing novel therapeutics","volume":"54","author":"Mehta","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.omtn.2026.103028_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.freeradbiomed.2005.01.019","article-title":"Reactive oxygen species and the modulation of stroke","volume":"38","author":"Crack","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.omtn.2026.103028_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1523\/JNEUROSCI.4973-07.2008","article-title":"Free radical production in CA1 neurons induces MIP-1alpha expression, microglia recruitment, and delayed neuronal death after transient forebrain ischemia","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2026.103028_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2019.08.008","article-title":"NR4A1 regulates cerebral ischemia-induced brain injury by regulating neuroinflammation through interaction with NF-\u03baB\/p65","volume":"518","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2026.103028_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review","volume":"8","author":"Shih","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtn.2026.103028_bib9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nri2655","article-title":"Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases","volume":"9","author":"Pasparakis","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2026.103028_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuint.2005.07.010","article-title":"Distinct nuclear factor-\u03baB\/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells","volume":"47","author":"Ishige","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.omtn.2026.103028_bib11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials","volume":"375","author":"Lees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2026.103028_bib12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa2118191","article-title":"Endovascular Therapy for Acute Stroke with a Large Ischemic Region","volume":"386","author":"Yoshimura","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103028_bib13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJMoa2213379","article-title":"Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct","volume":"388","author":"Huo","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103028_bib14","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJMoa2214403","article-title":"Trial of Endovascular Thrombectomy for Large Ischemic Strokes","volume":"388","author":"Sarraj","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103028_bib15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/17474930221090347","article-title":"Japan Stroke Society Guideline 2021 for the Treatment of Stroke","volume":"17","author":"Miyamoto","year":"2022","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.omtn.2026.103028_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10157-007-0495-2","article-title":"Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance","volume":"11","author":"Hishida","year":"2007","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.omtn.2026.103028_bib17","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.omtn.2026.103028_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamaneurol.2020.1264","article-title":"Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial","volume":"77","author":"Clemens","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtn.2026.103028_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103028_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.nano.2015.12.374","article-title":"Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFalpha siRNA in prevention of experimental neuroinflammation","volume":"12","author":"Yadav","year":"2016","journal-title":"Nanomedicine."},{"key":"10.1016\/j.omtn.2026.103028_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/mt.2011.291","article-title":"Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain","volume":"20","author":"Kim","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103028_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jneumeth.2011.09.023","article-title":"Knockdown of cortical transthyretin expression around implanted neural prosthetic devices using intraventricular siRNA injection in the brain","volume":"203","author":"Smith","year":"2012","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.omtn.2026.103028_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.omtn.2026.103028_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2026.103028_bib25","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.omtn.2026.103028_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.omtn.2026.103028_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2026.103028_bib28","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.2174\/138161282131151013191737","article-title":"Brain Targeting of siRNA via Intranasal Pathway","volume":"21","author":"Mohanty","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.omtn.2026.103028_bib29","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.bmc.2017.11.001","article-title":"Nose-to-brain peptide delivery - The potential of nanotechnology","volume":"26","author":"Samaridou","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omtn.2026.103028_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2017.11.047","article-title":"Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies","volume":"270","author":"Pires","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtn.2026.103028_bib31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.drudis.2018.01.005","article-title":"An update on the role of nanovehicles in nose-to-brain drug delivery","volume":"23","author":"Feng","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtn.2026.103028_bib32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/pharmaceutics11090478","article-title":"Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles","volume":"11","author":"Kanazawa","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.103028_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/pharmaceutics17010044","article-title":"Therapeutic Efficacy of Intranasal N-Acetyl-L-Cysteine with Cell-Penetrating Peptide-Modified Polymer Micelles on Neuropathic Pain in Partial Sciatic Nerve Ligation Mice","volume":"17","author":"Nango","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.103028_bib34","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2026.103028_bib35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.neuroscience.2008.07.007","article-title":"NF-kappaB signaling in cerebral ischemia","volume":"158","author":"Ridder","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtn.2026.103028_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5184","article-title":"Biophysical characterization of RelA-p52 NF-\u03baB dimer-A link between the canonical and the non-canonical NF-\u03baB pathway","volume":"33","author":"Dhaka","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.omtn.2026.103028_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.111.180042","article-title":"Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002","volume":"338","author":"Uchida","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.omtn.2026.103028_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/pharmaceutics7030294","article-title":"Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis","volume":"7","author":"Kanazawa","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.103028_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/pharmaceutics16020213","article-title":"TPGS-b-PBAE Copolymer-Based Polyplex Nanoparticles for Gene Delivery and Transfection In Vivo and In Vitro","volume":"16","author":"Ding","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.103028_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbrc.2012.03.155","article-title":"Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration","volume":"421","author":"Liang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2026.103028_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2012.10.039","article-title":"Investigation of the performance of PEG-PEI\/ROCK-II-siRNA complexes for Alzheimer's disease in vitro","volume":"1490","author":"Liu","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.omtn.2026.103028_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","article-title":"Block copolymer micelles for drug delivery: design, characterization and biological significance","volume":"47","author":"Kataoka","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2026.103028_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121117","article-title":"Dual RNA sequencing reveals the expression of unique transcriptomic signatures in lipopolysaccharide-induced BV-2 microglial cells","volume":"10","author":"Das","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.103028_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021891","article-title":"Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways","volume":"6","author":"Dai","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.103028_bib45","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.omtn.2026.103028_bib46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtn.2026.103028_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219869","article-title":"Negatively charged phospholipids doped liposome delivery system for mRNA with high transfection efficiency and low cytotoxicity","volume":"30","author":"Wang","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.omtn.2026.103028_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71798-1","article-title":"Dihydroxyphenylalanine-conjugated high molecular weight polyethylenimine for targeted delivery of Plasmid","volume":"14","author":"Taheri","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103028_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/pharmaceutics14010143","article-title":"Enzyme-Responsive Amphiphilic Peptide Nanoparticles for Biocompatible and Efficient Drug Delivery","volume":"14","author":"Song","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.103028_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpharm.2017.07.077","article-title":"Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide","volume":"530","author":"Kanazawa","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2026.103028_bib51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12951-024-02772-2","article-title":"Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2026.103028_bib52","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1523\/JNEUROSCI.3670-06.2006","article-title":"Bim and Noxa are candidates to mediate the deleterious effect of the NF-\u03baB subunit RelA in cerebral ischemia","volume":"26","author":"Inta","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2026.103028_bib53","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.STR.0000221708.17159.64","article-title":"Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury","volume":"37","author":"Crack","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.omtn.2026.103028_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047306","article-title":"Suppression of NF-kappaB reduces myocardial no-reflow","volume":"7","author":"Zeng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.103028_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa","volume":"10","author":"G\u00e4nger","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.103028_bib56","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.omtn.2026.103028_bib57","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2023.06.005","article-title":"Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys","volume":"359","author":"Sasaki","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtn.2026.103028_bib58","article-title":"Distribution of insulin in primate brain following nose-to-brain transport","volume":"10","author":"Smith","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.omtn.2026.103028_bib59","first-page":"1","article-title":"Optimized mucus adhesion and penetration of lipid-polymer nanoparticles enables effective nose-to-brain delivery of perillyl alcohol for glioblastoma therapy","author":"de Oliveira Junior","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.omtn.2026.103028_bib60","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.actbio.2025.01.036","article-title":"Enhanced nasal-to-brain drug delivery by multivalent bioadhesive nanoparticle clusters for cerebral ischemic reperfusion injury protection","volume":"194","author":"Jia","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.omtn.2026.103028_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1208\/s12249-025-03046-2","article-title":"Intranasal Delivery of Paclitaxel-Loaded Ligand Conjugated Polymeric Nanoparticles for Targeted Brain Delivery","volume":"26","author":"Deshmukh","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.omtn.2026.103028_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126471","article-title":"Nose to Brain Delivery of Transferrin conjugated PLGA nanoparticles for clonidine","volume":"252","author":"Sharma","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.omtn.2026.103028_bib63","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3762\/bjnano.15.113","article-title":"Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals","volume":"15","author":"Akpinar Adscheid","year":"2024","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.103028_bib64","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/ptr.7409","article-title":"Cardamonin attenuates cerebral ischemia\/reperfusion injury by activating the HIF-1alpha\/VEGFA pathway","volume":"36","author":"Ni","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.omtn.2026.103028_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102852","article-title":"Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2\/HO-1 pathway in MCAO mice","volume":"66","author":"Sun","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.omtn.2026.103028_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714943","article-title":"Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2\/STAT3 Pathway Inhibition","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.103028_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104808","article-title":"Glutamate-responsive translation of dendritic GSK3beta mRNA triggers a cycle for amplification of reactivated preexisting GSK3beta that is indispensable for tau hyperphosphorylation","volume":"139","author":"Tanaka","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.omtn.2026.103028_bib68","first-page":"1","article-title":"Generation of Cellular Reactive Oxygen Species by Activation of the EP2 Receptor Contributes to Prostaglandin E2-Induced Cytotoxicity in Motor Neuron-Like NSC-34 Cells","volume":"2020","author":"Kosuge","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.omtn.2026.103028_bib69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neulet.2011.11.017","article-title":"Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo","volume":"506","author":"Masuko","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtn.2026.103028_bib70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2004.10.018","article-title":"Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia","volume":"18","author":"P\u00e9rez-Asensio","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2026.103028_bib71","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.omtn.2026.103028_bib72","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600199X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600199X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:03:24Z","timestamp":1788879804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312600199X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S216225312600199X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103028","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal Tat-modified PEG-PCL nanomicelles delivering anti-RelA siRNA attenuate ischemia-reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103028"}}